Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

FOUND: Is moderna stock underperforming the nasdaq - What They Never Told You

Moderna, Inc. (MRNA), based in Cambridge, Massachusetts, is a leading biotechnology company specializing in mRNA therapeutics and vaccines. With a market cap of $30.4 billion, Moderna has transformed the pharmaceutical industry through its groundbreaking mRNA technology, developing treatments for various diseases.

Companies valued at $10 billion or more are generally considered "large-caps," and Moderna fits this criterion perfectly, signifying its substantial size, stability, and influence in the biotechnology industry.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.